Diflucortolone (Valerate)
Diflucortolone (Valerate) is a corticosteroid. Diflucortolone (Valerate) is used topically for inflammatory skin conditions.
Primary Characteristics
It is of Synthetic origin and belongs to Cortiocosteroid.
It is classified in Corticosteroid Topical pharmacological group. It is also classified under Dermatological Products .
Molecular Weight: 478.6 · Solubility in Water: insoluble · Solubility in Alcohol: slighty soluble · Non-proprietary name: Diflucortolone (Valerate).
Pharmacokinetics
None recorded.
Advertisement
Indications
Diflucortolone (Valerate) is primarily indicated in conditions like Burns, Contact dermatitis, Contact eczema, Erythrasma, Folliculitis, Impetigo, Insect bites, Lupus erythematosus discoides, Seborrhoic eczema, Sunburn.
Contraindications
Diflucortolone (Valerate) is contraindicated in conditions like Viral infection, Syphilis, Tuberculosis.
Dosage
Diflucortolone (Valerate)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 0.2 % | 0.2 % | Every 8h | Topical | Initial, Appleid to large areas when skin is broken. |
| 0.2 % | 0.2 % | Every 24h | Topical | Maintenance |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | SA | |
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
None recorded.
Side Effects
Diflucortolone (Valerate) in overdosage may give rise to further complications which include Telangiectasia.
Diflucortolone (Valerate) is known to cause more or less tolerable side effects which are usually transient. These include Acneform, Gingival hypertrophy, Hypertrichosis , Perioral dermatitis, Skin atrophy.
Warnings / Precautions
Available Brands
Storage Conditions
Drug Classification
- 1.13.3.2 — Corticosteroids combinations